Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has traditionally focused on the dissected segment. In daily practice, however, most ...

The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...

A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus® LANCELOT sutureless aortic valve, marking an important milestone in the evolution ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. | JenaValve has ...

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option ...

I’m a 79-year-old female. Recently, I was diagnosed with moderate calcification of leaflets on my mitral valve. I have no symptoms but heard from a recent talk that even moderate calcification could ...

Workers at a Kansas hospital failed to properly sterilize and disinfect open-heart surgery devices, leading to slow-growing M. chimaera infections and deaths, according to multiple lawsuits.